Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FL2C7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $387,705
Award facts
- Contract value 100% obligated
- $387,704.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $387,704.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/ml syringes, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a continuation of the company's substantial partnership with DLA, leveraging its established capability in distributing pharmaceutical products to military and federal healthcare facilities nationwide.
This award is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which authorizes firm fixed-price delivery orders for pharmaceutical supplies supporting Department of Defense healthcare sites globally. Stelara, a specialty biologic medication, falls within the company's extensive portfolio covering branded and generic prescription drugs, biologics, and medical consumables. The delivery order reflects DLA's continued reliance on DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain, with the company maintaining a consistent track record of fulfilling complex medical product requirements for military health facilities.
Quick answers
Who was awarded contract SPE2DB25FL2C7?
SPE2DB25FL2C7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 27, 2025.
How much is contract SPE2DB25FL2C7 worth?
The government has obligated $387,705 on SPE2DB25FL2C7.
Is contract SPE2DB25FL2C7 an order under another contract?
Yes. SPE2DB25FL2C7 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL2C7 competed?
The extent of competition for SPE2DB25FL2C7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award